| Primary | Prevalence of Different Neurological Disorders Associated With Depression Treated With Fluvoxamine (Fevarin®). | The primary neurologic diagnosis was coded according to International Classification of Diseases and Related Health Problems, revision 10 http://apps.who.int/classifications/icd10/browse/2010/en In the report all diseases were summarized by Classes. Percentage of patients reporting at least once a specified symptom during the treatment period. | The actual number of assessed patients was provided to each measure. | Posted | | Number | 95% Confidence Interval | Percentage | | Baseline | | | | ID | Title | Description |
|---|
| OG000 | Outpatients With Neurological Disorders and Depression. | Outpatients with mild or moderate symptoms of depression prescribed by Fevarin® in accordance with the approved local label. |
| | | Title | Denominators | Categories |
|---|
| International Classification of Diseases G00-G99 | | | | International Classification of Diseases I00-I99 | | | | International Classification of Diseases M00-M99 |
| |
| Secondary | Change in the Hospital Anxiety and Depression Scale (HADS) Depression Subscale Score | | The actual number of assessed patients was provided to each measure. | Posted | | Mean | Standard Deviation | units on a scale | | From Baseline up to Day 30 and Day 90 | | | | ID | Title | Description |
|---|
| OG000 | Outpatients With Neurological Disorders and Depression. | Outpatients with mild or moderate symptoms of depression prescribed by Fevarin® in accordance with the approved local label. |
| |
| Secondary | Percent of Patients With Change of Depression Symptoms From Baseline to Day 30 | | The actual number of assessed patients was provided to each measure. | Posted | | Number | | percentage of participants | | From Baseline up to Day 30 | | | | ID | Title | Description |
|---|
| OG000 | Outpatients With Neurological Disorders and Depression. | Outpatients with mild or moderate symptoms of depression prescribed by Fevarin® in accordance with the approved local label. |
| | |
| Secondary | Change in the Hospital Anxiety and Depression Scale (HADS) Anxiety Subscale Score | | The actual number of assessed patients was provided to each measure. | Posted | | Mean | Standard Deviation | units on a scale | | From Baseline up to Day 30 and Day 90 | | | | ID | Title | Description |
|---|
| OG000 | Outpatients With Neurological Disorders and Depression. | Outpatients with mild or moderate symptoms of depression prescribed by Fevarin® in accordance with the approved local label. |
| |
| Secondary | Change in the Clinical Condition Measured by Clinical Global Impression Scale - Severity of Illness Subscale | Clinical Global Impression Scale (CGI) was used. CGI is in the public domain. Severity of illness is the subscale of Clinical Global Impression (CGI). Severity of illness - reported in this place 0 = Not assessed, 1 = Normal, not at all ill, 2 = Borderline mentally ill, 3 = Mildly ill, 4 = Moderately ill, 5 = Markedly ill, 6 = Severely ill, 7 = Among the most extremely ill patients | The actual number of assessed patients was provided to each measure. | Posted | | Mean | Standard Deviation | units on a scale | | Baseline, Day 90 | | | | ID | Title | Description |
|---|
| OG000 | Outpatients With Neurological Disorders and Depression. | Outpatients with mild or moderate symptoms of depression prescribed by Fevarin® in accordance with the approved local label. |
| |
| Secondary | Percent of Patients With Change in Clinical Global Impression Scale | | The actual number of assessed patients was provided to each measure. | Posted | | Number | | percentage of participants | | From Baseline up to Day 90 | | | | ID | Title | Description |
|---|
| OG000 | Outpatients With Neurological Disorders and Depression. | Outpatients with mild or moderate symptoms of depression prescribed by Fevarin® in accordance with the approved local label. |
| | |
| Secondary | Anxiety and Depression Symptoms Score Measured by Hospital Anxiety and Depression Scale (HADS) | | The actual number of assessed patients was provided to each measure. | Posted | | Mean | Standard Deviation | units on a scale | | Up to 180 days | | | | ID | Title | Description |
|---|
| OG000 | Outpatients With Neurological Disorders and Depression. | Outpatients with mild or moderate symptoms of depression prescribed by Fevarin® in accordance with the approved local label. |
| |
| Secondary | Percent of Patients With Change of Anxiety Symptoms From Baseline to Day 30. | | The actual number of assessed patients was provided to each measure. | Posted | | Number | | percentage of participants | | From Baseline up to Day 30 | | | | ID | Title | Description |
|---|
| OG000 | Outpatients With Neurological Disorders and Depression. | Outpatients with mild or moderate symptoms of depression prescribed by Fevarin® in accordance with the approved local label. |
| | |
| Secondary | Gender | | | Posted | | Number | | percentage of participants | | Baseline | | | | ID | Title | Description |
|---|
| OG000 | Outpatients With Neurological Disorders and Depression. | Outpatients with mild or moderate symptoms of depression prescribed by Fevarin® in accordance with the approved local label. |
| | | Title | Denominators | Categories |
|---|
| Female |
|
| Secondary | Race | | | Posted | | Number | | percentage of participants | | Baseline | | | | ID | Title | Description |
|---|
| OG000 | Outpatients With Neurological Disorders and Depression. | Outpatients with mild or moderate symptoms of depression prescribed by Fevarin® in accordance with the approved local label. |
| | | Title | Denominators | Categories |
|---|
| Asian |
|
| Secondary | Family Status | | | Posted | | Number | | percentage of participants | | Baseline | | | | ID | Title | Description |
|---|
| OG000 | Outpatients With Neurological Disorders and Depression. | Outpatients with mild or moderate symptoms of depression prescribed by Fevarin® in accordance with the approved local label. |
| | | Title | Denominators | Categories |
|---|
| Civil marriage |
|
| Secondary | Education | | | Posted | | Number | | percentage of participants | | Baseline | | | | ID | Title | Description |
|---|
| OG000 | Outpatients With Neurological Disorders and Depression. | Outpatients with mild or moderate symptoms of depression prescribed by Fevarin® in accordance with the approved local label. |
| | | Title | Denominators | Categories |
|---|
| Elementary |
|
| Secondary | Employment | | | Posted | | Number | | percentage of participants | | Baseline | | | | ID | Title | Description |
|---|
| OG000 | Outpatients With Neurological Disorders and Depression. | Outpatients with mild or moderate symptoms of depression prescribed by Fevarin® in accordance with the approved local label. |
| | | Title | Denominators | Categories |
|---|
| Employed |
|
| Other Pre-specified | Cognitive Functions Measured by Montreal Cognitive Assessment (MOCA) | MoCA test used under license agreement www.mocatest.org Scale range 0-30 Normal >=26 Higher values represent a better outcome | The actual number of assessed patients was provided to each measure. | Posted | | Mean | Standard Deviation | units on a scale | | Baseline, Day 90, Up to 180 days | | | | ID | Title | Description |
|---|
| OG000 | Outpatients With Neurological Disorders and Depression. | Outpatients with mild or moderate symptoms of depression prescribed by Fevarin® in accordance with the approved local label. |
| |
| Other Pre-specified | Insomnia Severity Index | Insomnia Severity Index (ISI) used under license agreement cmorin@psy.ulaval.ca Total score has the range from 0 to 28 points with the following categories: 0-7 = No clinically significant insomnia 8-14 = Subthreshold insomnia 15-21 = Clinical insomnia (moderate severity) 22-28 = Clinical insomnia (severe). Higher values represent a worse outcome | The actual number of assessed patients was provided to each measure. | Posted | | Mean | Standard Deviation | units on a scale | | Baseline, Day 90, Up to 180 days | | | | ID | Title | Description |
|---|
| OG000 | Outpatients With Neurological Disorders and Depression. | Outpatients with mild or moderate symptoms of depression prescribed by Fevarin® in accordance with the approved local label. |
| |
| Other Pre-specified | Percent of Patients With Quality of Sleep Change Assessed by Insomnia Severity Index (ISI) at Day 90 | Percent of Patients With Quality of Sleep Change Assessed by Insomnia Severity Index (ISI) From Baseline to Day 90. | The actual number of assessed patients was provided to each measure. | Posted | | Number | | percentage of participants | | From baseline up to Day 90 | | | | ID | Title | Description |
|---|
| OG000 | Outpatients With Neurological Disorders and Depression. | Outpatients with mild or moderate symptoms of depression prescribed by Fevarin® in accordance with the approved local label. |
| |
| Other Pre-specified | Change in the Clinical Condition Measured by Clinical Global Impression Scale - Severity of Illness Subscale From Day 90 to 180 Days | Clinical Global Impression Scale (CGI) was used. CGI is in the public domain. Severity of illness is the subscale of Clinical Global Impression (CGI). Severity of illness - reported in this place 0 = Not assessed, 1 = Normal, not at all ill, 2 = Borderline mentally ill, 3 = Mildly ill, 4 = Moderately ill, 5 = Markedly ill, 6 = Severely ill, 7 = Among the most extremely ill patients | The actual number of assessed patients was provided to each measure. | Posted | | Mean | Standard Deviation | units on a scale | | From Day 90 up to Up to 180 days | | | | ID | Title | Description |
|---|
| OG000 | Outpatients With Neurological Disorders and Depression. | Outpatients with mild or moderate symptoms of depression prescribed by Fevarin® in accordance with the approved local label. |
| |
| Other Pre-specified | Percent of Patients With Change in Clinical Global Impression Scale - Global Improvement Subscale Assessed at Day 180 | Global improvement - qualitative scale 0 = Not assessed, 1 = Very much improved , 2 = Much improved, 3 = Minimally improved, 4 = No change, 5 = Minimally worse, 6 = Much worse, 7 = Very much worse | The actual number of assessed patients was provided to each measure. | Posted | | Number | | percentage of participants | | From Day 90 up to 180 days | | | | ID | Title | Description |
|---|
| OG000 | Outpatients With Neurological Disorders and Depression. | Outpatients with mild or moderate symptoms of depression prescribed by Fevarin® in accordance with the approved local label. |
| |